martes, 13 de diciembre de 2022

FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC | FDA

FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC | FDA

No hay comentarios:

Publicar un comentario